Edap Tms (NASDAQ:EDAP) Coverage Initiated at StockNews.com

StockNews.com assumed coverage on shares of Edap Tms (NASDAQ:EDAPFree Report) in a research report sent to investors on Tuesday morning. The firm issued a hold rating on the medical equipment provider’s stock.

Several other research analysts also recently commented on EDAP. HC Wainwright restated a “buy” rating and issued a $19.00 target price on shares of Edap Tms in a research note on Friday, March 28th. Piper Sandler cut their target price on Edap Tms from $5.00 to $4.50 and set an “overweight” rating for the company in a research note on Friday, March 28th. Finally, Jefferies Financial Group restated a “hold” rating and issued a $2.00 target price (down previously from $8.00) on shares of Edap Tms in a research note on Friday, April 4th.

Read Our Latest Report on EDAP

Edap Tms Price Performance

Shares of NASDAQ EDAP opened at $2.15 on Tuesday. The stock has a fifty day moving average of $2.00 and a 200-day moving average of $2.29. The stock has a market cap of $79.77 million, a PE ratio of -3.31 and a beta of 0.12. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.46 and a current ratio of 2.18. Edap Tms has a fifty-two week low of $1.26 and a fifty-two week high of $7.40.

Edap Tms (NASDAQ:EDAPGet Free Report) last issued its earnings results on Thursday, March 27th. The medical equipment provider reported ($0.05) EPS for the quarter, topping the consensus estimate of ($0.11) by $0.06. Edap Tms had a negative return on equity of 44.21% and a negative net margin of 34.92%. The business had revenue of $22.69 million during the quarter, compared to the consensus estimate of $20.83 million. Equities research analysts anticipate that Edap Tms will post -0.6 earnings per share for the current year.

Institutional Trading of Edap Tms

Institutional investors and hedge funds have recently modified their holdings of the business. Illumine Investment Management LLC purchased a new stake in shares of Edap Tms in the 4th quarter valued at about $50,000. Rock Springs Capital Management LP raised its holdings in shares of Edap Tms by 1.5% in the 4th quarter. Rock Springs Capital Management LP now owns 1,591,800 shares of the medical equipment provider’s stock valued at $3,518,000 after acquiring an additional 23,800 shares in the last quarter. Millennium Management LLC raised its holdings in shares of Edap Tms by 218.5% in the 4th quarter. Millennium Management LLC now owns 48,915 shares of the medical equipment provider’s stock valued at $108,000 after acquiring an additional 33,558 shares in the last quarter. BNP Paribas Financial Markets raised its holdings in shares of Edap Tms by 111.5% in the 4th quarter. BNP Paribas Financial Markets now owns 48,650 shares of the medical equipment provider’s stock valued at $108,000 after acquiring an additional 25,650 shares in the last quarter. Finally, Jane Street Group LLC raised its holdings in shares of Edap Tms by 174.7% in the 4th quarter. Jane Street Group LLC now owns 31,361 shares of the medical equipment provider’s stock valued at $69,000 after acquiring an additional 73,361 shares in the last quarter. Hedge funds and other institutional investors own 62.74% of the company’s stock.

Edap Tms Company Profile

(Get Free Report)

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology.

Further Reading

Receive News & Ratings for Edap Tms Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edap Tms and related companies with MarketBeat.com's FREE daily email newsletter.